Lexeo Therapeutics, Inc Common Stock
Price & Volume
Stats
See moreOpen | $4.10 |
Previous Close | $4.13 |
Day Range | $3.99-$4.17 |
52W Range | $4.03-$10.99 |
Market Cap | $324.2M |
Shares Short | 16M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$62.3M |
Diluted EPS | -$1.12 |
News
See moreYahoo Finance • 20 days ago
What Makes Lexeo Therapeutics (LXEO) One of The Best Stocks Under $10 That Could Triple
Yahoo Finance • 2 months ago
Lexeo Therapeutics Announces Publication in JAMA Cardiology of Phase I/II Data for LX2006 in Friedreich Ataxia
Yahoo Finance • 2 months ago
Pre-Market Movers: BYAH, LXEO, ELTX Swing Big
Yahoo Finance • 4 months ago
Lexeo Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
About
CEO | Mr. R. Nolan Townsend M.B.A. |
CFO | Mr. Louis Tamayo |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 59 |